bile-salt-stimulated lipase
Recombinant proteinexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00659243)
Timeline
Indications
Mechanism of action
- Cholesterol esteraseSupplementation
CEL supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bile-salt-stimulated lipase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01413581 | Phase 3 | May 1, 2011 | Swedish Orphan Biovitrum |
| NCT00743483 | Phase 2 | Aug 1, 2008 | Erasmus University Rotterdam, Swedish Orphan Biovitrum |
| NCT00658905 | Phase 2 | Apr 1, 2008 | Biovitrum AB, Swedish Orphan Biovitrum |
| NCT00659243 | Phase 2 | Mar 1, 2008 | Biovitrum AB, Swedish Orphan Biovitrum |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Swedish Orphan Biovitrum | For profit | 4 | 4 | 2 | 2008 |
| Biovitrum AB | For profit | 2 | 0 | 1 | 2008 |
| Erasmus University Rotterdam | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1